Upgrade to SI Premium - Free Trial

Biogen (BIIB) Shares Should Trade Higher on CTAD Data - BMO Capital

December 9, 2016 6:29 AM
BMO Capital analyst M. Ian Somaiya expects shares of Biogen (NASDAQ: BIIB) to trade higher CTAD data, which show: 1) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA

Next Articles